Chromogranin A in the central nervous system of the rat: Pan-neuronal expression of its mRNA and selective expression of the protein

Neuropeptides

Volumn 33, Issue 4, 1999, Pages 285-300

  Woulfe, J ^a   Deng, D ^b   Munoz, D ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN PROTECTION; CENTRAL NERVOUS SYSTEM; MALE; MESSENGER RNA SYNTHESIS; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; RAT; SECRETORY GRANULE;

EID: 0032745496     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.1999.0043     Document Type: Article

References (37)

1. Blaschko H., Combie R. S., Schneider F. H., Silver M., Smith A. D. Secretion of a chromaffin granule protein, chromogranin from the adrenal gland after splanchnic stimulation. Nature. 215:1967;58-59.
2. Kilpatrick L., Gavine F., Apps D., Phillips J. Biosynthetic relationship between the major matrix proteins of adrenal chromaffin granules. Fedn Eur Biochem Socs Lett. 164:1983;383-388.
3. Fischer-Colbrie R., Lassmann H., Hagn C., Winkler H. Immunological studies of the distribution of chromogranin A and B in endocrine and nervous tissues. Neuroscience. 16:1985;547-555.
4. Lassmann H., Hagn C., Fischer-Colbrie R., Winkler H. Presence of chromogranin A, B, and C in bovine endocrine and nervous tissues. A comparative immunohistochemical study. Histochem J. 18:1986;380-386.
5. Eiden L. E., Huttner W. B., Mallet J., O'Connor D. T., Winkler H., Zanini A. A nomenclature proposed for the chromogranin/secretogranin proteins. Neuroscience. 21:1987;1019-1021.
6. Konecki D. S., Benedum U. M., Gerdes H-H., Huttner W. B. The primary structure of human chromogranin A and pancreastatin. J Biol Chem. 262:1987;17,026-17,030.
7. Somogyi P., Hodgson A. J., DePotter R. W. Chromogranin immunoreactivity in the central nervous system. Immunochemical characterization, distribution, and relationship to catecholaminergic and enkephalin pathways. Br Res Rev. 8:1984;193-230.
8. Nolan J. A., Trojanowski J. Q., Hogue-Angeletti R. Neurons and neuroendocrine cells contain chromogranin: detection of the molecule in normal bovine tissues by immunochemical and immunohistochemical methods. J Histochem Cytochem. 33:1985;791-798.
9. Schafer M. K-N., Nohr D., Romeo H., Eiden L. E., Weihe E. Pan-neuronal expression of CgA in rat nervous system. Peptides. 15:1994;263-279.
10. Rosa P., Hille A., Lee R. W. H., Zanini A., DeCamilli P., Huttner W. B. Secretogranins I and II: two tyrosine-sulfated secretory proteins common to a variety of cells secreting peptides by the regulated pathway. J Cell Biol. 10:1985;1999-2011.
11. Iacangelo A., Affolter H. U., Eiden L. E., Herbert E., Grimes M. Bovine chromogranin A: its sequence and the distribution of its mRNA in endocrine tissues. Nature. 323:1986;82-86.
12. Gorr S-U., Kumarasamy R., Dean W. L., Cohn D. V. New suggestions for the physiological role of secretory protein I. Bone Miner. 2:1987;251-255.
13. Gorr S-U., Dean W. L., Radley T. L., Cohn D. V. Calcium binding and aggregation properties of parathyroid secretory protein I (chromogranin A). Bone Miner. 4:1988;17-25.
14. Reiffen F. U., Gratzi M. Chromogranins, widespread in endocrine and nervous tissue, bind calcium. FEBS Lett. 195:1986;327-330.
15. Reiffen F. U., Gratzi M. Calcium binding to chromaffin vesicle matrix proteins: effect of pH, magnesium, and ionic strength. Biochemistry. 25:1986;4402-4406.
16. Munoz D. G. The distribution of chromogranin A-like immunoreactivity in the human hippocampus coincides with the pattern of resistance to epilepsy-induced neuronal damage. Ann Neurol. 27:1990;266-275.
17. Seidah N. G., Hendy G. N., Paquin J. H. Chromogranin A can act as a reversible processing enzyme inhibitor. Fedn Eur Biochem Socs Lett. 211:1987;144-150.
18. Helle K. B., Angeletti R. H. Chromogranin A: a mutipurpose prohormone? Acta Physiol Scand. 152:1994;1-10.
19. Munoz D. G., Kobylinski L., Henry D. D., George D. H. Chromogranin A-like immunoreactivity in the human brain: distribution in bulbar medulla and cerebral cortex. Neuroscience. 34:1990;533-543.
20. Iacangelo I., Okayama H., Eiden L. E. Primary structures of rat chromogranin A and distribution of its mRNA. FEBS Lett. 227:1988;115-121.
21. Mahata M., Mahata S. K., Fischer-Colbrie R., Winkler H. Ontogenic development and distribution of mRNAs of chromogranin A and B, secretogranin II, p65, and synapsin/synaptophysin in rat brain. Dev Br Res. 76:1993;43-58.
22. Wilson B. S., Lloyd R. V. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol. 115:1984;458-468.
23. Wilson B. S., Phan S. H., Lloyd R. V. Chromogranin from normal human adrenal glands: purification by monoclonal antibody affinity chromatography and partial N-terminal amino acid sequence. Regul Pept. 13:1986;207-223.
24. Westerman R., Stogbauer F., Unsicker K. Calcium dependence of chromogranin A-catecholamine interaction. FEBS Lett. 239:1988;203-206.
25. Lloyd R. V., Wilson B. S. Specific endocrine tissue marker defined by a monoclonal antibody. Science. 222:1983;628-630.
26. Helman L. J., Ahn T. G., Levine M. A. Molecular cloning and primary structure of human chromogranin A (secretory protein). J Biol Chem. 263:1988;11,559-11,563.
27. O'Connor D. T., Cervenka J. H., Stone R. A. Chromogranin A immunoreactivity in human cerebrospinal fluid: properties, relationship to noradrenergic neuronal activity, and variation in neuronal disease. Neuroscience. 56:1993;999-1007.
28. Blennow K., Davidson P., Wallin A., Ekman R. Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer's disease? Dementia. 6:1995;306-311.
29. O'Connor D. T., Kailasam M. T., Thal L. J. Cerebrospinal fluid chromogranin A is unchanged in Alzheimer dementia. Neurobiol Ageing. 14:1993;267-269.
30. Sekiya K., Haji M., Fukahori M. Pancreastatin-like immunoreactivity of cerebrospinal fluid in patients with Alzheimer type dementia: evidence of aberrant processing of pancreastatin in Alzheimer type dementia. Neurosci Lett. 177:1994;123-126.
31. Miller C., Kirchmair R., Troger J. Cerebrospinal fluid of neuroleptic-naïve first episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin). Biol Psychiatr. 39:1996;911-918.
32. Ericsson A., Kovacs K. J., Sawchenko P. E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci. 14:1994;897-913.
33. McAuliffe W. G., Hess A. Human chromogranin A-like immunoreactivity in the Bergmann glia of the rat brain. Glia. 3:1990;13-16.
34. Wilkins G. P. Astrocyte heterogeneity. TINS. 13:1990;43-46.
35. Shinoda K., Marini A. M., Cosi C., Schwartz J. P. Brain region and gene specificity of neuropeptide gene expression in cultured astrocytes. Science. 245:1989;415-417.
36. Bunn S. J., Hanley M. R., Wilkin G. P. Evidence for a kappa opioid receptor on pituitary astrocytes. An autoradiographic study. Neurosci Lett. 55:1985;317-323.
37. Barbin G., Katz D. M., Chamak B., Glowinski J., Prochiantz A. Brain astrocytes express region-specific surface glycoproteins in culture. Glia. 1:1988;96-103.